Journal article
Immunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: A randomized trial
S Niyomnaitham, ZQ Toh, PV Licciardi, P Wongprompitak, K Srisutthisamphan, KK Copeland, K Chokephaibulkit
Journal of Infection | Published : 2022
Grants
Awarded by National Science and Technology Development Agency
Funding Acknowledgements
We acknowledge the support from the Dr. Anan Jongkaewwat-tana, National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science Development Agency (NSTDA).